APC and colorectal carcinoma: Further, ICG-001 preferentially reduced cell growth and viability in the cancer cell lines, and a water soluble version of ICG-001 reduced the formation of intestinal neoplasms in the Min mouse model of APC mutation initiated CRC, demonstrating preliminary in vivo efficacy of these agents [3].